Follow Us on StockTwits

Analyst Actions and Breaking News

Posted by on March 8, 2017 7:27 AM
Tags:
Categories: Business

Overnight Analyst Actions:

Raised:

IPXL Buy Deutsche Banc Securities

Initiates:

BLCM Outperform Wells Fargo Securities
QRVO Market Perform Wells Fargo Securities

Cuts:

IPXL Net Neutral Susquehanna Financial Group

Overnight Headlines By Ticker:

ALQA Alliqua, Inc.

3/7 16:19 Reports Q4 -$0.17 v -$0.19e, R$4.9M v $5.0Me

ALXN Alexion Pharmaceuticals Inc.

3/8 06:31 FDA accepts sBLA Filing of Soliris (Eculizumab) as a potential treatment for patients with refractory generalized Myasthenia Gravis (gMG)

BLCM Bellicum Pharmaceuticals

3/8 00:29 Wells Fargo Initiates BLCM with Outperform

DKS Dicks Sporting Goods Inc

3/8 07:07 CitiGroup Reiterates DKS with Buy, price target: $65

3/8 06:47 RBC Reiterates DKS with Outperform, price target: $61

3/8 05:25 UBS Reiterates DKS with Buy, price target: $55

3/8 01:13 JPMorgan Chase and Co Reiterates DKS with Neutral, price target: $54

GE General Electric Co

3/8 08:45 Announces power deal with Caithness that could exceed $1B to build HA combined-cycle power plants in US

3/8 08:40 Affirms FY17 EPS $1.60-1.70 v $1.69e; organic growth 3-5% Targeting mid-2017 close on merger with Baker Hughes (timing on track) – investor meeting slides (update)

HAIN Hain Celestial Group Inc.

3/8 08:45 UK’s CMA investigating anticipated acquisition of Yorkshire Provender Ltd

HALO Halozyme Therapeutics, Inc.

3/7 17:09 Investor relations confirms that management has canceled out of an upcoming conference because of a timing conflict with the May 4th annual shareholders meeting

IPXL Impax Laboratories

3/8 07:16 Susquehanna Cuts IPXL to Net Neutral from Net Positive, price target: $10

3/8 04:31 Deutsche Bank Raised IPXL to Buy from Hold, price target: $11

OPK Opko Health Inc

3/8 08:00 Receives EU Orphan Drug Status for new Oligonucleotide to treat Genetic Neurological Disorder

PTLA Portola Pharmaceuticals

3/7 16:05 Announces Betrixaban and AndexXa (andexanet alfa) presentations at American College of Cardiology’s (ACC) 66th Annual Scientific Session & Expo

QRVO Qorvo, Inc

3/7 17:35 Wells Fargo Initiates QRVO with Market Perform

TLGT Teligent, Inc

3/8 08:00 FDA approves Clobetasol Propionate Gel, 0.05%; Expects to launch in 2Q17

3/7 16:04 Reports Q4 $0.01 adj v -$0.01e, R$17.9M v $17.8Me (1 est)

TSLA Tesla Inc (formerly Tesla Motors)

3/7 20:49 Names Gary Clark as new CIO – financial press

VRX Valeant Pharmaceuticals International

3/8 08:40 Mizuho Securities Reiterates VRX with Underperform, price target: $9

3/7 17:01 Commences tender for up to $600M 6.75% 2018 notes